ArticleScience progress
Association between ROX index and in-hospital mortality in critically ill patients with chronic obstructive pulmonary disease: A retrospective cohort study based on two large databases.
Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveThe ROX index, combining oxygenation and respiratory rate, is widely used to assess respiratory failure. However, its prognostic value in critically ill patients with chronic obstructive pulmonary disease (COPD) remains unclear. This study aimed to explore the association between the ROX index and mortality in ICU patients with COPD.MethodsThis retrospective cohort study included patients with COPD from two large databases: MIMIC-IV (v3.1) and eICU-CRD (v2.0). The ROX index was calculated within the first 24 hours of ICU admission. The primary outcome was in-hospital mortality, with ICU mortality and 28-day mortality as secondary outcomes. Cox regression models, Kaplan-Meier survival curves, restricted cubic spline (RCS) analysis, and subgroup analyses were used to evaluate the association between ROX and mortality.ResultsA total of 1,639 patients from the MIMIC-IV cohort and 2,170 from the eICU-CRD cohort were included. In multivariable Cox regression, a higher ROX index was independently associated with a lower risk of in-hospital mortality (MIMIC-IV: HR = 0.96, 95% CI: 0.93-0.98; eICU-CRD: HR = 0.95, 95% CI: 0.92-0.98). Similar associations were observed for ICU and 28-day mortality. RCS analysis demonstrated a linear negative correlation between ROX and the risk of death. Subgroup analyses showed consistent results across various clinical strata. The E-value analysis suggested that a considerable amount of unaccounted confounding would be necessary to invalidate the observed associations.ConclusionsThe ROX index is inversely associated with mortality in critically ill patients with COPD, with higher values indicating better prognosis. It may serve as a simple, non-invasive, and valuable tool for early risk stratification in the ICU setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.